Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sotiris Vandoros

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Social Science & Medicine (1982)|June 11, 2020
Excess mortality during the Covid-19 pandemic: Early evidence from England and WalesSotiris Vandoros
Health Economics|May 23, 2013
Therapeutic substitution post-patent expiry: the cases of ACE inhibitors and proton pump inhibitorsSotiris Vandoros
American Journal of Epidemiology|February 21, 2020
Invited Commentary: The Association Between Florida's Opioid Crackdown and Opioid-Related Mortality-The Roles of Economic Factors and Mortality MisclassificationSotiris Vandoros
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|May 8, 2021
COVID-19, lockdowns and motor vehicle collisions: empirical evidence from GreeceSotiris Vandoros
Health Policy (Amsterdam, Netherlands)|September 11, 2012
Reforms in the Greek pharmaceutical market during the financial crisisSotiris Vandoros, Tom Stargardt
Preventive Medicine Reports|February 5, 2016
Now or later? Understanding the etiologic period of suicideSotiris Vandoros, Georgios Kavetsos
European Journal of Epidemiology|June 11, 2021
Economic uncertainty and suicide in the United StatesSotiris Vandoros, Ichiro Kawachi
Health Policy (Amsterdam, Netherlands)|December 25, 2017
Healthcare reforms in Cyprus 2013-2017: Does the crisis mark the end of the healthcare sector as we know it?Panagiotis Petrou, Sotiris Vandoros
Accident; Analysis and Prevention|March 24, 2019
The relative risk of motor vehicle collision on cannabis celebration day in Great BritainSotiris Vandoros, Ichiro Kawachi
Health Policy (Amsterdam, Netherlands)|April 4, 2015
Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatmentPanagiotis Petrou, Sotiris Vandoros
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Social Science & Medicine (1982)|June 11, 2020
Excess mortality during the Covid-19 pandemic: Early evidence from England and WalesSotiris Vandoros
Health Economics|May 23, 2013
Therapeutic substitution post-patent expiry: the cases of ACE inhibitors and proton pump inhibitorsSotiris Vandoros
American Journal of Epidemiology|February 21, 2020
Invited Commentary: The Association Between Florida's Opioid Crackdown and Opioid-Related Mortality-The Roles of Economic Factors and Mortality MisclassificationSotiris Vandoros
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|May 8, 2021
COVID-19, lockdowns and motor vehicle collisions: empirical evidence from GreeceSotiris Vandoros
Health Policy (Amsterdam, Netherlands)|September 11, 2012
Reforms in the Greek pharmaceutical market during the financial crisisSotiris Vandoros, Tom Stargardt
Preventive Medicine Reports|February 5, 2016
Now or later? Understanding the etiologic period of suicideSotiris Vandoros, Georgios Kavetsos
European Journal of Epidemiology|June 11, 2021
Economic uncertainty and suicide in the United StatesSotiris Vandoros, Ichiro Kawachi
Health Policy (Amsterdam, Netherlands)|December 25, 2017
Healthcare reforms in Cyprus 2013-2017: Does the crisis mark the end of the healthcare sector as we know it?Panagiotis Petrou, Sotiris Vandoros
Accident; Analysis and Prevention|March 24, 2019
The relative risk of motor vehicle collision on cannabis celebration day in Great BritainSotiris Vandoros, Ichiro Kawachi
Health Policy (Amsterdam, Netherlands)|April 4, 2015
Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatmentPanagiotis Petrou, Sotiris Vandoros
Pageof 4